Mri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancer

Simple item page
dc.coverageDOI: 10.3390/diagnostics11091551
dc.creatorSamtani, Suraj
dc.creatorBurotto, Mauricio
dc.creatorRoman, Juan Carlos
dc.creatorCortes-Herrera, Daniela
dc.creatorWalton-Diaz, Annerleim
dc.date2021
dc.date.accessioned2025-11-18T19:56:25Z
dc.date.available2025-11-18T19:56:25Z
dc.description<p>Prostate cancer (PCa) is one of the most frequent causes of cancer death worldwide. Historically, diagnosis was based on physical examination, transrectal (TRUS) images, and TRUS biopsy resulting in overdiagnosis and overtreatment. Recently magnetic resonance imaging (MRI) has been identified as an evolving tool in terms of diagnosis, staging, treatment decision, and follow-up. In this review we provide the key studies and concepts of MRI as a promising tool in the diagnosis and management of prostate cancer in the general population and in challenging scenarios, such as anteriorly located lesions, enlarged prostates determining extracapsular extension and seminal vesicle invasion, and prior negative biopsy and the future role of MRI in association with artificial intelligence (AI).</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/c0f6b1a9-61ad-4dc9-932e-9833b1257b88
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/59789
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.11 (2021) nr.9
dc.subjectActive surveillance
dc.subjectArtificial intelligence
dc.subjectDiagnosis
dc.subjectMRI
dc.subjectProstate cancer
dc.subjectSDG 3 - Good Health and Well-being
dc.titleMri and targeted biopsy essential tools for an accurate diagnosis and treatment decision making in prostate cancereng
dc.typeReview articleeng
dc.typeArtículo de revisiónspa
Files
Collections
PURE